Trial Search Results

Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer

This study will investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic or recurrent breast cancer.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute of Mental Health (NIMH)

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Supportive-Expressive Group Therapy plus education
  • Behavioral: Education

Phase:

N/A

Eligibility


Inclusion Criteria:

Women were eligible for the study if they had documented metastatic or recurrent breast
cancer, were proficient enough in English to be able to complete questionnaires and
participate in a support group, were living in the Greater San Francisco Bay Area, and had
a Karnofsky score of at least 70%.19 Exclusion Criteria:

Women were excluded if they had any of the following risk factors: positive supraclavicular
lymph nodes as the only metastatic lesion at the time of initial diagnosis; active
non-breast cancers within the past 10 years; or other concurrent medical conditions likely
to influence short-term survival. Basal cell or squamous cell carcinomas of the skin, in
situ cancer of the cervix, or melanoma with a Breslow depth less than 0.76 mm were allowed.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting